Jorgen Smeby
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment of localized rectal cancer in the Nordic countries-comparison of Nordic to Dutch, ESMO, and NCCN guidelines.
Journal: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
Published: July 20, 2026
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.
Journal: Cell reports. Medicine
Published: December 11, 2025
Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends.
Journal: ESMO gastrointestinal oncology
Published: August 02, 2024
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer.
Journal: ESMO open
Published: September 11, 2020
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.
Journal: EBioMedicine
Published: February 11, 2020
Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer.
Journal: ESMO open
Published: April 01, 2019
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.
Journal: Oncogenesis
Published: November 01, 2018
CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 09, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026